Speed of symptom relief viewed as primary concern for chronic bronchitis patients

Published: 2004-08-06 06:57:00

Updated: 2004-08-06 06:57:00

A recent European six-country survey of 1,100 ACEB (acute exacerbations of chronic bronchitis) patients, conducted by Psyma International Medical Marketing Research and sponsored by Bayer HealthCare, revealed that more than half (55%) wanted an antibiotic that provides faster symptom relief.

The same survey also found that 67% of AECB patients have suffered symptoms (including coughing, fati...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.